Re‐evaluation of rituximab therapy for idiopathic Castleman disease: retrospective study from single‐center experience

This article has been accepted for publication and undergone full peer review but has not been through the copyediting, typesetting, pagination and proofreading process, which may lead to differences between this version and the Version of Record. Please cite this article as doi:10.1111/ejh.13739

留言 (0)

沒有登入
gif